Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy

Overview of attention for article published in Patient preference and adherence, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Oral formulations and lipophilic salts of methylnaltrexone

Grant US-10507206-B2

United States of America

Oral formulations and lipophilic salts of methylnaltrexone

Grant US-10376505-B2

United States of America

Stable pharmaceutical formulations of methylnaltrexone

Grant US-10376584-B2

United States of America

Oral formulations and lipophilic salts of methylnaltrexone

Grant US-10307417-B2

United States of America